CAPR

Capricor Therapeutics (CAPR)

About Capricor Therapeutics (CAPR)

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Details

Daily high

$13.53

Daily low

$12.57

Price at open

$12.64

52 Week High

$23.40

52 Week Low

$3.52

Market cap

594.3M

Dividend yield

0.00%

Volume

5.9M

Avg. volume

1.8M

P/E ratio

-12.31

Capricor Therapeutics News